Solid Cancers

Also known as: Solid Cancer

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB12180	Apitolisib	1	Completed	2
DB11595	Atezolizumab	1	Active Not Recruiting	1
DB11595	Atezolizumab	1	Completed	4
DB00112	Bevacizumab	1	Completed	7
DB06772	Cabazitaxel	1	Completed	1
DB01101	Capecitabine	1	Completed	1
DB00958	Carboplatin	1	Completed	2
DB14874	Cergutuzumab amunaleukin	1	Completed	1
DB00515	Cisplatin	1	Completed	1
DB05239	Cobimetinib	1	Terminated	1
DB00531	Cyclophosphamide	1	Recruiting	1
DB01248	Docetaxel	1	Active Not Recruiting	1
DB01248	Docetaxel	1	Completed	1
DB14905	Emactuzumab	1	Active Not Recruiting	1
DB08899	Enzalutamide	1	Active Not Recruiting	1
DB00977	Ethinylestradiol	1	Completed	1
DB01073	Fludarabine	1	Recruiting	1
DB00544	Fluorouracil	1	Active Not Recruiting	1
DB00947	Fulvestrant	1	Active Not Recruiting	1
DB12380	GDC-0152	1	Terminated	1
DB11982	GDC-0623	1	Completed	1
DB12336	GDC-0917	1	Completed	1
DB00441	Gemcitabine	1	Terminated	1
DB00105	Interferon alfa-2b	1	Completed	1
DB11743	Ipatasertib	1	Active Not Recruiting	1
DB11743	Ipatasertib	1	Completed	1
DB06186	Ipilimumab	1	Completed	1
DB01006	Letrozole	1	Active Not Recruiting	1
DB00650	Leucovorin	1	Active Not Recruiting	1
DB00683	Midazolam	1	Active Not Recruiting	1
DB00717	Norethisterone	1	Completed	1
DB08935	Obinutuzumab	1	Completed	2
DB00526	Oxaliplatin	1	Active Not Recruiting	1
DB01229	Paclitaxel	1	Active Not Recruiting	1
DB01229	Paclitaxel	1	Completed	3
DB01229	Paclitaxel	1	Terminated	1
DB14897	Parsatuzumab	1	Completed	2
DB00008	Peginterferon alfa-2a	1	Completed	1
DB00642	Pemetrexed	1	Completed	1
DB11663	Pictilisib	1	Completed	1
DB11663	Pictilisib	1	Terminated	1
DB00412	Rosiglitazone	1	Completed	1
DB05210	SF1126	1	Completed	1
DB14958	Selicrelumab	1	Completed	1
DB12108	Taselisib	1	Active Not Recruiting	1
DB06273	Tocilizumab	1	Completed	1
DB00072	Trastuzumab	1	Completed	1
DB15428	Vesencumab	1	Completed	2
DB08828	Vismodegib	1	Completed	3
DB11094	Vitamin D	1	Completed	1
DB11595	Atezolizumab	1 / 2	Recruiting	1
DB11714	Durvalumab	1 / 2	Recruiting	1
DB09035	Nivolumab	1 / 2	Recruiting	1
DB09037	Pembrolizumab	1 / 2	Recruiting	1
DB06366	Pertuzumab	2	Completed	1
DB08896	Regorafenib	2	Enrolling by Invitation	1
DB00135	Tyrosine	2	Enrolling by Invitation	1